Strategies to Innovate EmeRgENcy Care Clinical Trials Network (SIREN) - Clinical Coordinating Center (CCC)

创新紧急护理临床试验网络 (SIREN) 的策略 - 临床协调中心 (CCC)

基本信息

  • 批准号:
    10550501
  • 负责人:
  • 金额:
    $ 77.88万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2017
  • 资助国家:
    美国
  • 起止时间:
    2017-07-15 至 2028-01-31
  • 项目状态:
    未结题

项目摘要

The overall goal of the Strategies to Innovate Emergency Care Clinical Trials Network (SIREN) is to improve the outcome of patients suffering acute illness and injury by identifying effective treatments given in the earliest stages of care. Emergency conditions such as myocardial infarction, cardiac arrest, traumatic injury including brain and spinal cord injury, and seizures cause significant morbidity and mortality and exact a high cost in terms of human suffering and health care spending. Pre-clinical and translational research has demonstrated that there is a very narrow window of opportunity in which many novel treatments for emergency conditions are optimally effective, and that conducting research in the emergency setting presents unique pragmatic challenges to clinical investigators. Effective clinical trials in these conditions require a coordinated network of emergency physicians, surgeons, cardiologists, intensivists, neurologists and biostatisticians. This renewal application, in response to RFA-NS-22-014 describes the features, functions and coordination we will continue to provide as the Clinical Coordinating Center for the SIREN network. The key elements of this ongoing structure include an interdisciplinary team of investigators with specific expertise in the conduct of clinical trials of emergency interventions, a hub-and-spoke network design that acknowledges the importance of enrolling patients in the acute setting, and a long term network commitment to advancing the national research infrastructure as it relates to the interdisciplinary study of acute illness and injury. This project continues to create and maintain a coherent, collaborative, multidisciplinary emergency clinical trials community that is diverse and inclusive. The network will recruit, efficiently perform, and widely disseminate the most scientifically and clinically important trials necessary to advance the emergency care of patients with neurologic, cardiac, respiratory, hematologic and trauma emergencies. SIREN initiated 5 large, simple multicenter trials over the previous 5 year grant period, and will initiate at least 4 more in the next grant period. The network aims to transform the emergency research enterprise, by exploring innovations in clinical trial designs, by better and earlier engagement of patient stakeholders in trial planning, and by creative improvements in implementing and performing trials.
创新急救临床试验网络(SIREN)的总体目标是通过确定在护理的最早阶段给予的有效治疗来改善急性疾病和损伤患者的预后。诸如心肌梗塞、心脏骤停、包括脑和脊髓损伤在内的创伤性损伤以及癫痫发作等紧急状况导致显著的发病率和死亡率,并且在人类痛苦和医疗保健支出方面造成高昂的成本。临床前和转化研究表明,有一个非常狭窄的机会窗口,其中许多新的治疗紧急情况是最有效的,并在紧急情况下进行研究提出了独特的务实挑战,临床研究者。在这些条件下进行有效的临床试验需要急诊医生、外科医生、心脏病专家、重症监护医生、神经科医生和生物统计学家的协调网络。作为对RFA-NS-22-014的回应,本更新申请描述了我们将继续作为SIREN网络的临床协调中心提供的特性、功能和协调。这一持续结构的关键要素包括一个跨学科的研究人员团队,他们在紧急干预措施的临床试验方面具有特定的专业知识,一个中心辐射网络设计,承认在急性环境中招募患者的重要性,以及一个长期的网络承诺,以推进国家研究基础设施,因为它涉及急性疾病和损伤的跨学科研究。该项目将继续创建和维护一个一致的,协作的,多学科的紧急临床试验社区,这是多样化和包容性的。该网络将招募、有效执行和广泛传播最具科学和临床意义的必要试验,以促进神经、心脏、呼吸、血液和创伤急诊患者的急诊护理。SIREN在过去5年的资助期内启动了5项大型、简单的多中心试验,并将在下一个资助期内启动至少4项。该网络旨在通过探索临床试验设计的创新,通过患者利益相关者更好和更早地参与试验计划,以及通过实施和执行试验的创造性改进,来改变紧急研究企业。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

WILLIAM G BARSAN其他文献

WILLIAM G BARSAN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('WILLIAM G BARSAN', 18)}}的其他基金

Brain Oxygen Optimization in Severe Traumatic Brain Injury - Phase 3 (BOOST-3)
严重创伤性脑损伤中的脑氧优化 - 第 3 阶段 (BOOST-3)
  • 批准号:
    9730632
  • 财政年份:
    2018
  • 资助金额:
    $ 77.88万
  • 项目类别:
Brain Oxygen Optimization in Severe Traumatic Brain Injury - Phase 3 (BOOST-3)
严重创伤性脑损伤中的脑氧优化 - 第 3 阶段 (BOOST-3)
  • 批准号:
    10265997
  • 财政年份:
    2018
  • 资助金额:
    $ 77.88万
  • 项目类别:
Strategies to Innovate EmeRgENcy Care Clinical Trials Network (SIREN) - Clinical Coordinating Center (CCC)
创新紧急护理临床试验网络 (SIREN) 的策略 - 临床协调中心 (CCC)
  • 批准号:
    9757540
  • 财政年份:
    2018
  • 资助金额:
    $ 77.88万
  • 项目类别:
Hyperbaric Oxygen Brain Injury Treatment (HOBIT) Trial - CCC
高压氧脑损伤治疗 (HOBIT) 试验 - CCC
  • 批准号:
    9979966
  • 财政年份:
    2017
  • 资助金额:
    $ 77.88万
  • 项目类别:
Strategies to Innovate EmeRgENcy Care Clinical Trials Network (SIREN) - Clinical Coordinating Center (CCC)
创新紧急护理临床试验网络 (SIREN) 的策略 - 临床协调中心 (CCC)
  • 批准号:
    10246475
  • 财政年份:
    2017
  • 资助金额:
    $ 77.88万
  • 项目类别:
Hyperbaric Oxygen Brain Injury Treatment (HOBIT) Trial - CCC
高压氧脑损伤治疗 (HOBIT) 试验 - CCC
  • 批准号:
    10449195
  • 财政年份:
    2017
  • 资助金额:
    $ 77.88万
  • 项目类别:
Neurologic Emergencies Treatment Trials Network: Clinical Coordinating Center
神经急症治疗试验网络:临床协调中心
  • 批准号:
    8914779
  • 财政年份:
    2014
  • 资助金额:
    $ 77.88万
  • 项目类别:
Accelerating Drug and Device Evaluation through Innovative Clinical Trial Design
通过创新的临床试验设计加速药物和器械评估
  • 批准号:
    8068442
  • 财政年份:
    2010
  • 资助金额:
    $ 77.88万
  • 项目类别:
Accelerating Drug and Device Evaluation through Innovative Clinical Trial Design
通过创新的临床试验设计加速药物和器械评估
  • 批准号:
    8323322
  • 财政年份:
    2010
  • 资助金额:
    $ 77.88万
  • 项目类别:
Accelerating Drug and Device Evaluation through Innovative Clinical Trial Design
通过创新的临床试验设计加速药物和器械评估
  • 批准号:
    8149979
  • 财政年份:
    2010
  • 资助金额:
    $ 77.88万
  • 项目类别:

相似海外基金

Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 77.88万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 77.88万
  • 项目类别:
    Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 77.88万
  • 项目类别:
    Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 77.88万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 77.88万
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 77.88万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 77.88万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 77.88万
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 77.88万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
  • 批准号:
    484000
  • 财政年份:
    2023
  • 资助金额:
    $ 77.88万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了